Amprion

Amprion is a global leader in advancing the diagnosis of neurodegenerative disorders through seed amplification testing. Its primary product, the SAAmplify-ɑSYN biomarker test, aids in diagnosing synucleinopathies like Parkinson's and Lewy body dementia. The company also partners with pharmaceutical companies to develop new therapies.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $6M

Date: 19-Nov-2024

Investors: Formation Venture Engineering, Eli Lilly, Amprion’s Series A investors

Markets: Biotechnology, Diagnostics, Healthcare

HQ: San Diego, California, United States

Founded:

Website: https://ampriondx.com/

LinkedIn: https://www.linkedin.com/company/amprion

Twitter:

Instagram: